Cargando…
A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis
Hypertension-associated end-organ damage commonly leads to cardiac and renal fibrosis. As no effective anti-fibrotic therapy currently exists, the unchecked progression of fibrogenesis manifests as cardio-renal failure and early death. We have previously shown that FATp300—p300 with intrinsic factor...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788418/ https://www.ncbi.nlm.nih.gov/pubmed/28933600 http://dx.doi.org/10.1080/15592294.2017.1370173 |